Rotavirus Infections Drug pipeline Report 2020- Current Status, Phase, Mechanism, Route of Administration, Companies, and Clinical Trials of Pre-clinical and Clinical Drugs

October 2019 | 50 pages | ID: RDA375BF2435EN
VPAResearch

Abstracts

Rotavirus Infections Drug pipeline report- 2020 is an annual R&D review of Rotavirus Infections pipeline candidates. The report presents the current status of all major Rotavirus Infections therapeutic compounds. Detailed insights into Rotavirus Infections pipeline development, current status, companies, drug profiles and Rotavirus Infections preclinical and clinical trials are included.

2020 Rotavirus Infections Pipeline Market Insights
Rotavirus Infections disease overview, 2020 pipeline review, insights into leading companies, dominant mechanism of action, majority of administration route of Rotavirus Infections therapies, pipeline by phase and others are included.

Rotavirus Infections pipeline Drug profiles-
Active and inactive drug profiles covering information including drug name/synonym, sponsor/collaborators/Developer/originator, drug mechanism, route of administration, orphan drug status, NME, phase, development status, and others are included.

Rotavirus Infections Therapeutic Drug candidates
Both active and inactive Rotavirus Infections pipeline drug candidates are included in the report

Rotavirus Infections Clinical Trials and preclinical Studies
Rotavirus Infections In-vitro and In-vivo studies, discovery stage and pre-clinical stage trial details, Clinical trial titles, duration, location, phase, sponsors, and other details are provided.

Rotavirus Infections pipeline market developments
Rotavirus Infections Pipeline market news and deals including mergers, acquisitions, approvals, collaborations, trial initiations, results, investments, licensing opportunities and others are provided.

Rotavirus Infections pipeline companies in active development
The report analyzes Rotavirus Infections pipeline of the below companies-

Aridis Pharmaceuticals Inc, Beijing Minhai Biotechnology Co Ltd, Bharat Biotech International Ltd, Bio Farma, Biological E Ltd, Curevac AG, GlaxoSmithKline Plc, iQur Ltd, Mitsubishi Tanabe Pharma Corporation, MSD Wellcome Trust Hilleman Laboratories Pvt Ltd, Serum Institute of India Ltd, UMN Pharma Inc

Report Coverage

What to look out for in 2020
Drugs moving from early stage to mid-to-late stages and drugs to look after in 2020 are included

Pipeline Snapshot
Pipeline candidate count - Drug by phase, mechanism of action, route of administration, designation and others

Companies
12 Companies investing in Rotavirus Infections pipeline from discovery stage to pre-registration phase are included

Drug profiles
Over 10 details of each Rotavirus Infections pipeline candidate are included

Company Profiles
Business overview and contact details of all companies operating in the industry are provided

Market Developments
News, Developments and other recent industry developments are included

Contents

1. ROTAVIRUS INFECTIONS PIPELINE MARKET INSIGHTS, 2020

1.1 Rotavirus Infections Disease Overview
1.2 Rotavirus Infections Drug Pipeline Snapshot, 2020
  1.2.1 Rotavirus Infections Pipeline Drugs by Phase
  1.2.2 Rotavirus Infections Pipeline Drugs by Company
  1.2.3 Rotavirus Infections Pipeline Drugs by Mechanism of Action
  1.2.4 Rotavirus Infections Pipeline Drugs by Route of Administration

2. ROTAVIRUS INFECTIONS COMPANY WISE PIPELINE DETAILS

Aridis Pharmaceuticals Inc Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Beijing Minhai Biotechnology Co Ltd Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Bharat Biotech International Ltd Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Bio Farma Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Biological E Ltd Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Curevac AG Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
GlaxoSmithKline Plc Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
iQur Ltd Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Mitsubishi Tanabe Pharma Corporation Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
MSD Wellcome Trust Hilleman Laboratories Pvt Ltd Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
Serum Institute of India Ltd Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details
UMN Pharma Inc Rotavirus Infections Pipeline Drugs
  Company Profile
  Drug Candidate Details

3. ROTAVIRUS INFECTIONS DRUG PIPELINE PROFILES

3.1 Discovery and Preclinical Drug Profiles
3.2 Phase 1 Drug Profiles
3.3 Phase 2 Drug Profiles
3.4 Phase 3 Drug Profiles

4. ROTAVIRUS INFECTIONS PIPELINE NEWS AND DEVELOPMENTS

5. APPENDIX

5.1 Primary and Secondary Research Methodology
5.2 Publisher Expertize
5.3 Contacts